Collaboration focuses on the discovery of novel, non-CRBN/VHL, Targeted Glue degraders for oncology and immunology indications
By combining technologies, the companies hope to optimise the cell assay development workflow with automation
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.